Immediate Impact

2 by Nobel laureates 2 from Science/Nature 60 standout
Sub-graph 1 of 22

Citing Papers

MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Fibroblast and myofibroblast activation in normal tissue repair and fibrosis
2024 Standout
5 intermediate papers

Works of Christopher Andrew Johnson being referenced

Metastatic Melanoma Patient–Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition
2020
The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo
2017
and 1 more

Author Peers

Author Last Decade Papers Cites
Christopher Andrew Johnson 196 113 126 9 329
Claire Hardy 120 41 185 15 342
Lorenzo Spagnuolo 160 208 99 11 365
Johanna Mangana 220 50 123 12 333
Carolyn Van Pelt 175 20 169 12 357
Jonathan Zorea 113 42 138 12 261
Ginette S. Santiago-Sánchez 71 56 175 13 300
Oleg Schmidt-Kittler 87 131 147 10 351
Guillaume Gapihan 122 23 160 13 290
Jason V. Evans 85 35 141 12 290
Hye-Yeong Kim 64 107 91 15 350

All Works

Loading papers...

Rankless by CCL
2026